THERAPEUTIC CYCLIC COMPOUNDS AS IMMUNOMODULATORS
Номер патента: CU20170116A7
Опубликовано: 05-06-2018
Автор(ы): Muralidhara Ramachandra, Pottayil Govindan Nair Sasikumar, Seetharamaiah Setty Sudarshan Naremaddepalli
Принадлежит: Aurigene Discovery Tech Ltd
Опубликовано: 05-06-2018
Автор(ы): Muralidhara Ramachandra, Pottayil Govindan Nair Sasikumar, Seetharamaiah Setty Sudarshan Naremaddepalli
Принадлежит: Aurigene Discovery Tech Ltd
Реферат: <p>La presente invención hace referencia a compuestos cíclicos de fórmula (I)</p> <p>ESPACIO PARA LA FÓRMULA</p> <p>útiles para inhibir la vía de señalización de muerte celular programada 1 (PD-1) y/o para tratar trastornos mediante la inhibición de una señal de inmunosupresión inducida por PD-1, PD-L1 o PD-L2.</p> <p> The present invention refers to cyclic compounds of formula (I) </p> <p> FORMULA SPACE </p> <p> useful for inhibiting the programmed cell death signaling pathway 1 (PD-1 ) and / or to treat disorders by inhibiting an immunosuppression signal induced by PD-1, PD-L1 or PD-L2. </p>
Therapeutic cyclic compounds as immunomodulators
Номер патента: EP3267993A1. Автор: Muralidhara Ramachandra,Pottayil Govindan Nair Sasikumar,Seetharamaiah Setty Sudarshan Naremaddepalli. Владелец: Aurigene Discovery Technologies Ltd. Дата публикации: 2018-01-17.